Andreas Halman

Parkville, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development.

Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development.

Journal: Pharmacology research & perspectives

Published: June 11, 2026

Genetic Susceptibility to Anthracycline-Induced Cardiotoxicity in Australian Pediatric Cancer Patients: A Case-Control Study.

Genetic Susceptibility to Anthracycline-Induced Cardiotoxicity in Australian Pediatric Cancer Patients: A Case-Control Study.

Journal: JACC. Advances

Published: May 11, 2026

Effectiveness and tolerability of cannabidiol in paediatric epilepsy: a one-year multisite prospective study.

Effectiveness and tolerability of cannabidiol in paediatric epilepsy: a one-year multisite prospective study.

Journal: Epilepsy & behavior : E&B

Published: April 01, 2026

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5-HT3 Receptor Antagonists: 2026 Update.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5-HT3 Receptor Antagonists: 2026 Update.

Journal: Clinical pharmacology and therapeutics

Published: January 13, 2026

Tacrolimus in Pediatric Solid Organ Transplant Recipients: A Retrospective Cohort Study.

Tacrolimus in Pediatric Solid Organ Transplant Recipients: A Retrospective Cohort Study.

Journal: Pediatric transplantation

Published: November 03, 2025

Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study.

Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study.

Journal: Scientific reports

Published: September 17, 2025

Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption.

Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption.

Journal: Journal of psychoactive drugs

Published: February 21, 2025

Frequency and Implications of High-Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort.

Frequency and Implications of High-Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort.

Journal: Clinical and translational science

Published: February 17, 2025

Phenoconversion of CYP3A4, CYP2C19 and CYP2D6 in Pediatrics, Adolescents and Young Adults With Lymphoma: Rationale and Design of the PEGASUS Study.

Phenoconversion of CYP3A4, CYP2C19 and CYP2D6 in Pediatrics, Adolescents and Young Adults With Lymphoma: Rationale and Design of the PEGASUS Study.

Journal: Clinical and translational science

Published: December 22, 2024

Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global Dataset.

Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global Dataset.

Journal: Journal of psychoactive drugs

Published: November 23, 2024

Analysis of Tandem Repeats in Short-Read Sequencing Data: From Genotyping Known Pathogenic Repeats to Discovering Novel Expansions.

Analysis of Tandem Repeats in Short-Read Sequencing Data: From Genotyping Known Pathogenic Repeats to Discovering Novel Expansions.

Journal: Current protocols

Published: November 05, 2024

Changes in Pain and Mental Health Symptoms Associated with Prescribed Medicinal Cannabis Use: A One-Year Longitudinal Study.

Changes in Pain and Mental Health Symptoms Associated with Prescribed Medicinal Cannabis Use: A One-Year Longitudinal Study.

Journal: Journal of pain & palliative care pharmacotherapy

Published: October 21, 2024

Showing 1-12 of 27

Last Updated: 09/26/2026